Can biochemistry drive drug discovery beyond simple potency measurements?

Drug Discovery Today

Volumn 17, Issue 7-8, 2012, Pages 388-395

  Chène, Patrick ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; PROTEIN KINASE;

BIOLOGY; CHEMISTRY; CYTOLOGY; DRUG INDUSTRY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG SELECTIVITY; DRUG TARGETING; HUMAN; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; REVIEW;

BIOCHEMISTRY; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84859268097     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.01.022     Document Type: Review

References (75)

1. R.A. Copeland Evaluation of Enzyme Inhibitors in Drug Discovery 2005 Willey-Interscience
2. 50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
3. J. Yang Defining balanced conditions for inhibitor screening assays that target bisubstrate enzymes J. Biomol. Screen. 14 2009 111 120
4. M. Brockhoff Factors influencing the inhibition of protein kinases J. Enzyme Inhib. Med. Chem. 2011 10.3109/14756366.2011.583922
5. I.H. Segel Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems 1975 John Wiley & Sons
6. P. Chène The new challenges of biochemistry in identifying the next generation of protein kinase inhibitors Drug Discov. Today 13 2008 522 529
7. X. Gao, and T.K. Harris Steady-state kinetic mechanism of PDK1 J. Biol. Chem. 281 2006 21670 21681 (Pubitemid 44181870)
8. D. Vanderpool Characterization of the CHK1 allosteric inhibitor binding site Biochemistry 48 2009 9823 9830
9. M. Liu Kinetic studies of Cdk5/p25 kinase: phosphorylation of Tau and complex inhibition by two prototype inhibitors Biochemistry 47 2008 8367 8377
10. J.R. Burke BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice J. Biol. Chem. 278 2003 1450 1456 (Pubitemid 36801370)
11. R.A. Copeland Drug-target residence time and its implications for lead optimization Nat. Rev. Drug Discov. 5 2006 730 739 (Pubitemid 44323700)
12. D.C. Swinney Can binding kinetics translate to a clinically differentiated drug? From theory to practice Lett. Drug Des. Discov. 3 2006 569 574 (Pubitemid 44544011)
13. P.J. Tummino, and R.A. Copeland Residence time of receptor-ligand complexes and its effect on biological function Biochemistry 47 2008 5481 5492 (Pubitemid 351711169)
14. G. Vauquelin, and I. Van Liefde Slow antagonist dissociation and long-lasting in vivo receptor protection Trends Pharmacol. Sci. 27 2006 355 359 (Pubitemid 43963183)
15. J.A. Goodrich, and J.F. Kugel Binding and Kinetics for Molecular Biologists 2007 Cold Spring Harbor Laboratory Press
16. M. Golicnik, and J. Stojan Slow-binding inhibition Biochem. Mol. Biol. Educ. 32 2004 228 235
17. J.F. Morrison, and C.T. Walsh The behavior and significance of slow-binding enzyme inhibitors Adv. Enzymol. 61 1988 201 301
18. S.E. Szedlacsek, and R.G. Duggleby Kinetics of slow and tight-binding inhibitors Methods Enzymol. 249 1995 144 180
19. H. Iwata Biochemical characterization of TAK-593, a novel vEGFR/PDGFR inhibitor with a two-step slow binding Biochemistry 50 2011 738 751
20. C. Pargellis Inhibition of p38 MAP kinase by utilizing a novel allosteric site Nat. Struct. Biol. 9 2002 268 272 (Pubitemid 34289898)
21. G. Schreiber Fundamental aspects of protein-protein association kinetics Chem. Rev. 109 2009 839 860
22. M. Benveniste, and M.L. Mayer Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction Br. J. Pharmacol. 104 1991 207 221
23. A. Yiotakis Cyclic peptides with a phosphinic bond as potent inhibitors of a zinc bacterial collagenase J. Med. Chem. 37 1994 2713 2720 (Pubitemid 24273463)
24. C. Philipps Design and structure of stapled peptides binding to estrogen receptors J. Am. Chem. Soc. 133 2011 9696 9699
25. G. Schreiber, and A.R. Fersht Rapid, electrostatically assisted association of proteins Nat. Struct. Biol. 3 1996 427 431 (Pubitemid 26139441)
26. T. Selzer Rational design of faster associating and tighter binding protein complexes Nat. Struct. Biol. 7 2000 537 541 (Pubitemid 30445907)
27. J.E. Leffler Parameters for the description of transition states Science 117 1953 340 341
28. A.R. Fersht Relationship of Leffler (Brønsted) α values and protein folding Φ values to position of transition-state structures on reaction coordinates Proc. Natl. Acad. Sci. U. S. A. 101 2004 14338 14342 (Pubitemid 39346750)
29. D.U. Ferreiro Transition state for protein-DNA recognition Proc. Natl. Acad. Sci. U. S. A. 105 2008 10797 10802
30. A. Bachmann Mapping backbone and side-chain interactions in the transition state of a coupled protein folding and binding reaction Proc. Natl. Acad. Sci. U. S. A. 108 2011 3952 3957
31. J.M. Goldberg, and R.L. Baldwin A specific transition state for S-peptide combining with folded S-protein and then refolding Proc. Natl. Acad. Sci. U. S. A. 96 1999 2019 2024 (Pubitemid 29117860)
32. J.R. Horn Principal determinants leading to transition state formation of a protein-protein complex, orientation trumps side-chain interactions Proc. Natl. Acad. Sci. U. S. A. 106 2009 2259 2264
33. C. Kiel Electrostatically optimized Ras-binding Ral guanine dissociation stimulator mutants increase the rate of association by stabilizing the encounter complex Proc. Natl. Acad. Sci. U. S. A. 101 2004 9223 9228 (Pubitemid 38812856)
34. M.G. Taylor Kinetic epitope mapping of the chicken lysozyme HyHEL-10 Fab complex: delineation of docking trajectories Protein Sci. 7 1998 1857 1867
35. A.G. Turjanski Binding-induced folding of a natively unstructured transcription factor PLoS Comput. Biol. 4 2008 e1000060
36. E.R. Wood A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells Cancer Res. 64 2004 6652 6659 (Pubitemid 39297926)
37. P. Chène Study of the selectivity of insulin-like growth factor-1 receptor (IGF1R) inhibitors Open Enzyme Inhib. J. 3 2010 27 37
38. E.F. Johnson Pharmacological and functional comparison of the Polo-like kinase family: insight into inhibitor and substrate specificity Biochemistry 46 2007 9551 9563 (Pubitemid 47291962)
39. D.D. Boehr The role of dynamic conformational ensembles in biomolecular recognition Nat. Chem. Biol. 5 2009 789 796
40. G.G. Hammes Conformational selection or induced fit: a flux description of reaction mechanism Proc. Natl. Acad. Sci. U. S. A. 106 2009 13737 13741
41. T.R. Weikl, and V.C. Deuster Selected-fit versus induced-fit protein binding: kinetic differences and mutational analysis Proteins 75 2008 104 110
42. H.X. Zhou From induced fit to conformational selection: a continuum of binding mechanism controlled by the timescale of conformational transitions Biophys. J. 98 2010 L15 L17
43. J. Regan The kinetics of binding to p38 MAP kinase by analogues of BIRB 796 Bioorg. Med. Chem. Lett. 13 2003 3101 3104 (Pubitemid 36993646)
44. W.H.J. Ward, and G.A. Holdgate Isothermal titration calorimetry in drug discovery Prog. Med. Chem. 38 2001 309 376
45. K.W. Rickert Structural basis for selective small molecule kinase inhibition of activated c-Met J. Biol. Chem. 286 2011 11218 11225
46. A. Stroba 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds J. Med. Chem. 52 2009 4683 4693
47. A.N. Bullock Structural basis of inhibitor specificity of the protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase J. Med. Chem. 48 2005 7604 7614 (Pubitemid 41698801)
48. C.B. Breitenlechner Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants J. Med. Chem. 48 2005 163 170 (Pubitemid 40105257)
49. M.A. Seeliger c-src binds to the cancer drug Imatinib with an inactive abl/c-kit conformation and a distributed thermodynamic penalty Structure 15 2007 299 311 (Pubitemid 46366721)
50. G.G. Ferenczy, and G.M. Keseru Thermodynamics guided lead drug discovery and optimization Drug Discov. Today 15 2010 919 932
51. E. Freire Do enthalpy and entropy distinguish first in class from best in class? Drug Discov. Today 13 2008 869 874
52. A.J. Ruben Overcoming roadblocks in lead optimization: a thermodynamic perspective Chem. Biol. Drug Des. 67 2006 2 4 (Pubitemid 43881382)
53. A. Velazquez-Campoy The application of thermodynamic methods in drug design Thermochim. Acta 380 2001 217 227 (Pubitemid 33096436)
54. J.M. Sturtevant Heat capacity and entropy changes in process involving proteins Proc. Natl. Acad. Sci. U. S. A. 74 1977 2236 2240 (Pubitemid 8110685)
55. K. Gallagher, and K. Sharp Electrostatic contributions to heat capacity changes of DNA-ligand binding Biophys. J. 75 1998 769 776 (Pubitemid 28357518)
56. R.S. Spolar Use of liquid hydrocarbon and amide transfer data to estimate contributions to thermodynamic functions of protein folding from the removal of nonpolar and polar surface from water Biochemistry 31 1992 3947 3955
57. R. Talhout Understanding binding affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin J. Am. Chem. Soc. 125 2003 10570 10579 (Pubitemid 37055908)
58. C.P. Phenix, and D.R.J. Palmer Isothermal titration microcalorimetry reveals the cooperative and noncompetitive nature of inhibition of Sinorhizobium meliloti L5-30 dihydrodopicolinate synthase by (S)-lysine Biochemistry 47 2008 7779 7781
59. O. Anderka Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors Biochemistry 47 2008 4683 4691 (Pubitemid 351555489)
60. J.D. Dunitz Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions Chem. Biol. 2 1995 709 712
61. M.S. Searle, and D.H. Williams The cost of conformational order: entropy changes in molecular associations J. Am. Chem. Soc. 114 1992 10690 10697
62. A. Cornish-Bowden Enthalpy-entropy compensation: a phantom phenomenon J. Biosci. 27 2002 121 126 (Pubitemid 34218614)
63. D.M. Ford Enthalpy-entropy compensation is not a general feature of weak association J. Am. Chem. Soc. 127 2005 16167 16170 (Pubitemid 41689244)
64. T. Keleti Errors in the evaluation of Arrhenius and van't Hoff plots Biochem. J. 209 1983 277 280
65. G. Weber Persistent confusion of total entropy and chemical system entropy in chemical thermodynamics Proc. Natl. Acad. Sci. U. S. A. 93 1996 7452 7453 (Pubitemid 26277054)
66. B. Baum Non additivity of functional group contributions in protein-ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry J. Mol. Biol. 397 2010 1042 1054
67. V.M. Krishnamurthy The paradoxical thermodynamic basis for the interaction of ethylene glycol, glycine, and sarcosine chains with bovine carbonic anhydrase II: an unexpected manifestation of enthalpy/entropy compensation J. Am. Chem. Soc. 128 2006 5802 5812 (Pubitemid 43724384)
68. V. Lafont Compensating enthalpic and entropic changes hinder binding affinity optimization Chem. Biol. Drug Des. 69 2007 413 422 (Pubitemid 46955533)
69. E.M. Wilfong A multidisciplinary approach to probing enthalpy-entropy compensation and interfacial mobility model J. Am. Chem. Soc. 133 2011 11515 11523
70. A.A. Edwards Conformational states of human purine nucleoside phosphorylase at rest, at work and with transition state analogues Biochemistry 49 2010 2058 2067
71. C. Diehl Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3 J. Am. Chem. Soc. 132 2010 14577 14589
72. A. Whitty Cooperativity and biological complexity Nat. Chem. Biol. 4 2008 435 439 (Pubitemid 352019765)
73. D.H. Williams Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes Angew. Chem. Int. Ed. 43 2004 6596 6616 (Pubitemid 40018986)
74. C.A. Hunter, and S. Tomas Cooperativity, partially bound states, and enthalpy-entropy compensation Chem. Biol. 10 2003 1023 1032 (Pubitemid 37496432)
75. L. Muley Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors J. Med. Chem. 53 2010 2126 2135